ЦЕРЕБРАЛЬНАЯ ГИПОПЕРФУЗИЯ И КОГНИТИВНЫЕ НАРУШЕНИЯ


Цитировать

Полный текст

Аннотация

Обсуждается проблема взаимозависимости функций головного мозга и мозгового кровотока. Рассматриваются причины, механизмы развития и последствия церебральной гипоперфузии, в т. ч. развитие когнитивных нарушений у пациентов со сниженным мозговым кровотоком, а также возможности коррекции сниженного кровотока.

Об авторах

P R Kamchatnov

K A Zaytsev

Павел Рудольфович Камчатнов

НИЦ ГОУ ВПО РГМУ Кафедра неврологи и нейрохирургии, Москва

НИЦ ГОУ ВПО РГМУ Кафедра неврологи и нейрохирургии, Москва

К А Зайцев

ГУП ПВЛ № 7 ДЗ, Москва

ГУП ПВЛ № 7 ДЗ, Москва

Список литературы

  1. Бокерия Л.А., Камчатнов П.Р., Ключников И.В. Цереброваскулярные расстройства у больных с коронарным шунтированием // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. № 3. C. 90-95.
  2. Гусев Е.И., Скворцова В.И. Ишемия головного мозга. М., 2001 C.. 327.
  3. Камчатнов П.Р., Каралкин А.В., Чугунов А.В. и соавт. Возможности патогенетической терапии больных сахарным диабетом 2-го типа и дисциркуляторной энцефалопатией // Журнал неврологии и психиатрии им. С.С. Корсакова. 2008. № 3. C. 18-24.
  4. Танашян М.М., Домашенко М.А. Трентал при ишемических цереброваскулярных заболеваниях (обзор литературы). Атмосфера // Нервные болезни. 2005. № 4. C. 21-25.
  5. Baron J. Perfusion thresholds in human cerebral ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis 2001;11(1):2-8.
  6. Bladin C, Chambers B. Clinical features, pathogenesis and computed tomographic characteristics of internal watershed infarction. Stroke 1993;24:1925-32.
  7. Broe M, Kril J, Halliday G. Astrocytic degeneration relates to the severity of disease in frontotemporal dementia. Brain 2004;127:2214-20.
  8. Brun A. Pathology and pathophysiology of cerebrovascular dementia: pure subgroups of obstructive and hypoperfusive etiology. Dementia 1994;5:145-47.
  9. Caffarra P, Ghetti C, Letizia C, et al. Differential Patterns of Hypoperfusion in Subtypes of Mild Cognitive Impairment. The Open Neuroimaging Journal 2008;2:20-28.
  10. Charlesworth D, Likosky D, Marrin C, et al. Development and validation of a prediction model for strokes after coronary artery bypass grafting. Ann Thorac Surg 2003;76:436-43.
  11. Dai W, Lopez O, Carmichael O, et al. Mild Cognitive Impairment and Alzheimer Disease: Patterns of Altered Cerebral Blood Flow at MR Imaging Radiology 2009;250(3):856-66.
  12. DeCarli C, Miller B, Swan G, et al. Predictors of brain morphology for the men of the NHLBI twin study. Stroke 1999;30:529-36.
  13. Desmond D, Moroney J, Sano M, et al. Incidence of Dementia After Ischemic Stroke: Results of a Longitudinal Study. Stroke 2002;33:2254-62.
  14. Farkas E, De Vos R, Steur E, et al. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related? Neurobiol Aging 2000;21(2):235-43.
  15. de Groot J, de Leeuw F, Oudkerk M, et al. Cerebral white matter lesions and cognitive function: The Rotterdam Scan Study. Ann Neurol 2000;47:145-51.
  16. de la Torre J. Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord 2000;14(1):72-81.
  17. Gonzalez M, Selwyn A. Endothelial function, inflammation, and prognosis in cardiovascular disease. Am J Med. 2003;115(8):99-106.
  18. Hadjiev D, Mineva P. Antihypertensive treatment in elderly hypertensives without a history of stroke and the risk of cognitive disorders. Acta Neurol Scand 2008;118(3):139-45.
  19. Hunter J, Chien K. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999;341:1276-83.
  20. Jefferson A, Poppas A, Paul R, et al. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging 2007;28:477-83.
  21. Jefferson A, Tate D, Poppas A, et al. Lower Cardiac Output Is Associated with Greater White Matter Hyperintensities in Older Adults with Cardiovascular Disease. J Am Geriatr Soc 2007;55(7):1044-48.
  22. Johnson N, Jahng GH, Weiner M, et al. Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience. Radiology 2005;234:851-59.
  23. Johnston S, O'Meara S, Manolio A, et al. Cognitive Impairment and Decline Are Associated with Carotid Artery Disease in Patients without Clinically Evident Cerebrovascular Disease. Ann Intern Med. 2004;140:237-47.
  24. Lazarus R, Prettyman R, Cherryman G. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders. Int J Geriatr Psychiatry 2005;20:274-79.
  25. Lovenstone S, Gauthier S. Management of dementia. London: Martin Dunitz 2001.
  26. Mathiesen E, Waterloo K, Joakimsen O, et al. Reduced neuropsychological test performance in asymptomatic carotid stenosis: The Tromso Study. Neurology 2004;62(5):695-701.
  27. Nagamachi S, Nishikawa T, Ono S, et al. Regional cerebral blood flow in diabetic patients: evaluation by N-isopropyl-123I-IMP with SPECT. Nucl Med Commun 1994;15:455-60.
  28. Pantoni L, Garcia J. Cognitive impairment and cellular/vascular changes in the cerebral white matter. Ann N Y Acad Sci 1997;826:92-102.
  29. Pantoni L. Treatment of vascular dementia: evidence from trials with non-cholinergic drugs. J Neurol Sci 2004;226(1-2):67-70.
  30. Pavics L, Grunwald F, Reichmann K, et al. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test and Alzheimer's dementia. Eur J Nucl Med 1999;26:239-45.
  31. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008;7(8):683-9.
  32. Raetsch C, Jia J, Boigk G, et al. Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis. Gut 2002;50:241-47.
  33. Rosenberg G, Sullivan N, Esiri M. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke 2001;32:1162-68.
  34. Roman G. Perspectives in the treatment of vascular dementia. Drugs Today (Barc) 2000;36(9):641-53.
  35. Sabri O, Hellwig D, Schreckenberger M, et al. Influence of diabetes mellitus on regional cerebral glucose metabolism and regional cerebral blood flow. Nucl Med Commun 2000;21:19-29.
  36. Sarti C, Pantoni L, Bartolini L, et al. Cognitive impairment and chronic cerebral hypoperfusion: what can be learned from experimental models. J Neurol Sci 2002;203-204:263-266.
  37. Savas S, Delibas N, Savas C, et al. Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits Spinal Cord 2002;40:224-29.
  38. Sha M, Callahan C. The efficacy of pentoxifylline in the treatment of vascular dementia: a systematic review. Alzheimer Dis Assoc Disord 2003;17(1):46-54.
  39. Shaw S, Shah M, Williams S, et al. Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 2009;11(2):113-18.
  40. Shibata M, Ohtani R, Ihara M, et al. White Matter Lesions and Glial Activation in a Novel Mouse Model of Chronic Cerebral Hypoperfusion. Stroke 2004;35;2598-603.
  41. Shimizu S, Zhang Y, Laxamana J, et al. Concordance and Discordance Between Brain Perfusion and Atrophy in Frontotemporal Dementia. Brain Imaging and Behavior 2010;4:46-54.
  42. Soneira C, Scott T. Severe cardiovascular disease and Alzheimer's disease: senile plaque formation in cortical areas. Clin Anat 1996;9:118-27.
  43. Sulkava R, Erkinjuntti T. Vascular dementia due to cardiac arrhythmias and systemic hypotension. Acta Neurol Scand 1987;76:123-28.
  44. Suter OC, Sunthorn T, Kraftsik R, et al. Cerebral Hypoperfusion Generates Cortical Watershed Microinfarcts in Alzheimer Disease. Stroke 2002;33;1986-92.
  45. Tiehuis A, van den Berg E, et al. Cerebral perfusion in relation to cognitive function and type 2 diabetes. Diabetologia 2008;51:1321-26.
  46. Tosun D, Schuff N, Weiner M. An Integrated Multimodality MR Brain Imaging Study: Gray Matter Tissue Loss Mediates The Association Between Cerebral Hypoperfusion and Alzheimer's Disease. Conf Proc IEEE Eng Med Biol Soc 2009;1:6981-84.
  47. Tsuchiya M, Sako K, Yura S, et al. Cerebral blood flow and histopathological changes following permanent bilateral carotid artery ligation in Wistar rats. Exp Brain Res 1992;89:87-92.
  48. Ueno M, Tomimoto H, Akiguchi I, et al. Blood-brain barrier is disrupted in the white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 2002;22:97-104.
  49. van Laar P, van der G, Mali W, et al. Effect of cerebrovascular risk factors on regional cerebral blood flow. Radiology 2008;246:198-204.

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© ООО «Бионика Медиа», 2010

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах